Cite
Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers
MLA
Silvio Hemmi, et al. “Efficacy of CD46-Targeting Chimeric Ad5/35 Adenoviral Gene Therapy for Colorectal Cancers.” Oncotarget, vol. 7, no. 25, May 2016, pp. 38210–23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75dc065203c9d54e5f64692c2689d4aa&authtype=sso&custid=ns315887.
APA
Silvio Hemmi, Se-Young Kwon, Keesook Lee, Sang Jin Lee, Changjong Moon, Minsoo Kim, Young-Eun Joo, Manh-Hung Do, Young-Suk Cho, Chaeyong Jung, & Kwonseop Kim. (2016). Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers. Oncotarget, 7(25), 38210–38223.
Chicago
Silvio Hemmi, Se-Young Kwon, Keesook Lee, Sang Jin Lee, Changjong Moon, Minsoo Kim, Young-Eun Joo, et al. 2016. “Efficacy of CD46-Targeting Chimeric Ad5/35 Adenoviral Gene Therapy for Colorectal Cancers.” Oncotarget 7 (25): 38210–23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75dc065203c9d54e5f64692c2689d4aa&authtype=sso&custid=ns315887.